InMed Pharmaceuticals Inc. (INM)
NASDAQ: INM · Real-Time Price · USD
4.230
-0.120 (-2.76%)
Nov 20, 2024, 4:00 PM EST - Market closed
InMed Pharmaceuticals Employees
InMed Pharmaceuticals had 13 employees as of June 30, 2024. The number of employees did not change compared to the previous year.
Employees
13
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$381,577
Profits / Employee
-$524,353
Market Cap
2.82M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
CareMax | 1,450 |
Regional Health Properties | 114 |
Sintx Technologies | 43 |
Matinas BioPharma Holdings | 32 |
Theriva Biologics | 22 |
TNF Pharmaceuticals | 6 |
Avenue Therapeutics | 3 |
INM News
- 1 day ago - InMed Announces Publication of Study on Anti-Inflammation by Modulation of Endocannabinoid System - Newsfile Corp
- 6 days ago - InMed Reports First Quarter Fiscal 2025 Financial Results and Provides Business Update - Newsfile Corp
- 12 days ago - InMed Announces Share Consolidation to Satisfy Nasdaq Listing Rules - Newsfile Corp
- 15 days ago - InMed Pharmaceuticals Announces Decision by NASDAQ Hearings Panel to Grant Exception to Implement Share Consolidation to Satisfy NASDAQ Listing Rules - Newsfile Corp
- 24 days ago - InMed Pharmaceuticals Files Additional Patent Application for INM-901 in the Treatment of Neurodegenerative Conditions Including Alzheimer's Disease - Newsfile Corp
- 4 weeks ago - InMed to Participate in Fierce Biotech Webinar on Neuroinflammation in Alzheimer's Disease - Newsfile Corp
- 4 weeks ago - InMed Appoints Dr. Barry Greenberg, Johns Hopkins University School of Medicine, to its Scientific Advisory Board - Newsfile Corp
- 7 weeks ago - InMed Pharmaceuticals Reports Full Year Fiscal 2024 Financial Results and Provides Business Update - Newsfile Corp